Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (31-40 of 315) with videos related to

Pageof 32
Sort By:
Cancer Cell|August 16, 2017
Choose and Use Your Chemical Probe Wisely to Explore Cancer BiologyJulian Blagg, Paul Workman
RSC Medicinal Chemistry|December 22, 2022
The era of high-quality chemical probesMarco P Licciardello, Paul Workman
Trends in Molecular Medicine|April 3, 2002
Translating basic cancer research into new cancer therapeuticsPaul Workman, Stanley B Kaye
Nature Reviews. Drug Discovery|November 30, 2013
Drugging cancer genomesPaul Workman, Bissan Al-Lazikani
Cancer Discovery|January 16, 2013
Unpicking the combination lock for mutant BRAF and RAS melanomasBissan Al-Lazikani, Paul Workman
Journal of the American Pharmacists Association : Japha|November 8, 2014
Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristicsSteven R Erickson, Paul Workman
FEBS Letters|June 15, 2007
Inhibitors of the heat shock response: biology and pharmacologyMarissa V Powers, Paul Workman
Current Opinion in Pharmacology|August 6, 2008
Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicinePaul Workman, Johann de Bono
Molecular Cancer Therapeutics|November 11, 2011
Discovering and developing PI3 kinase inhibitors for cancer: rapid progress through academic-biotech-pharma interactionsFlorence I Raynaud, Paul Workman
Annual Review of Pharmacology and Toxicology|January 13, 2012
Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeuticsTimothy A Yap, Paul Workman
Pageof 32

Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Cancer Cell|August 16, 2017
Choose and Use Your Chemical Probe Wisely to Explore Cancer BiologyJulian Blagg, Paul Workman
RSC Medicinal Chemistry|December 22, 2022
The era of high-quality chemical probesMarco P Licciardello, Paul Workman
Trends in Molecular Medicine|April 3, 2002
Translating basic cancer research into new cancer therapeuticsPaul Workman, Stanley B Kaye
Nature Reviews. Drug Discovery|November 30, 2013
Drugging cancer genomesPaul Workman, Bissan Al-Lazikani
Cancer Discovery|January 16, 2013
Unpicking the combination lock for mutant BRAF and RAS melanomasBissan Al-Lazikani, Paul Workman
Journal of the American Pharmacists Association : Japha|November 8, 2014
Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristicsSteven R Erickson, Paul Workman
FEBS Letters|June 15, 2007
Inhibitors of the heat shock response: biology and pharmacologyMarissa V Powers, Paul Workman
Current Opinion in Pharmacology|August 6, 2008
Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicinePaul Workman, Johann de Bono
Molecular Cancer Therapeutics|November 11, 2011
Discovering and developing PI3 kinase inhibitors for cancer: rapid progress through academic-biotech-pharma interactionsFlorence I Raynaud, Paul Workman
Annual Review of Pharmacology and Toxicology|January 13, 2012
Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeuticsTimothy A Yap, Paul Workman
Pageof 32